Having tasted blockbuster success with its irritable bowel syndrome (IBS) drug Linzess, Ironwood Pharmaceuticals is willing to pay $1 billion…
Browsing: Business
Though much of Freenome’s focus has been on its blood test for the early detection of colorectal cancer, the company…
For physicians overall, intriguing trends showed up this year — an improvement in gender-based pay disparity in primary care; a…
Envision Healthcare has reached a restructuring agreement with its stakeholders, including ASC management center AmSurg, after announcing plans to file for bankruptcy.…
An industry-first FDA approval for a nonalcoholic steatohepatitis (NASH) therapy may still be a ways off. After reviewing Intercept Pharmaceuticals’…
Whether you believe this this figurative adage or not, it is a hard truth. Money is ubiquitous; it pervades everyday…
Following plans to file for Chapter 11 bankruptcy, Envision Healthcare reached a restructuring agreement with its stakeholders. Under the agreement, AmSurg and Envision Physician…
Reports record results, raises full-year guidance, accelerates path to positive free cash flow First quarter highlights MADISON, Wis., May 9, 2023 /PRNewswire/ — Exact…
Takeda may have caught attention recently for ending work on its early-stage gene therapy R&D, but a close reading of…
Physician staffing firm Envision Healthcare is planning to file for Chapter 11 bankruptcy, according to a report from The Wall Street Journal.…